Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021

SELL
$101.99 - $166.36 $562,576 - $917,641
-5,516 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$141.6 - $179.06 $59,188 - $74,847
-418 Reduced 7.04%
5,516 $914,000
Q1 2021

May 14, 2021

BUY
$132.81 - $182.18 $67,865 - $93,093
511 Added 9.42%
5,934 $828,000
Q4 2020

Feb 12, 2021

BUY
$138.17 - $184.34 $343,766 - $458,637
2,488 Added 84.77%
5,423 $939,000
Q3 2020

Nov 04, 2020

BUY
$114.09 - $145.51 $342 - $436
3 Added 0.1%
2,935 $409,000
Q2 2020

Jul 28, 2020

BUY
$89.45 - $129.85 $262,267 - $380,720
2,932 New
2,932 $350,000
Q4 2018

Feb 11, 2019

SELL
$35.43 - $56.29 $138,389 - $219,868
-3,906 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$44.22 - $75.47 $21,712 - $37,055
-491 Reduced 11.17%
3,906 $223,000
Q2 2018

Aug 14, 2018

SELL
$72.38 - $92.5 $1,519 - $1,942
-21 Reduced 0.48%
4,397 $351,000
Q1 2018

May 14, 2018

SELL
$69.46 - $88.57 $1.75 Million - $2.23 Million
-25,132 Reduced 85.05%
4,418 $383,000
Q4 2017

Feb 14, 2018

SELL
$65.94 - $93.31 $111,768 - $158,160
-1,695 Reduced 5.42%
29,550 $2.04 Million
Q3 2017

Nov 13, 2017

SELL
$80.87 - $91.08 $301,725 - $339,819
-3,731 Reduced 10.67%
31,245 $2.84 Million
Q2 2017

Aug 14, 2017

BUY
N/A
34,976
34,976 $2.6 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $140M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.